The Development of Vancomycin Resistance in a Patient with Methicillin-ResistantStaphylococcus aureusInfection
Open Access
- 18 February 1999
- journal article
- case report
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 340 (7) , 517-523
- https://doi.org/10.1056/nejm199902183400704
Abstract
Over the past two decades, vancomycin has been considered the antibiotic of choice for methicillin-resistant Staphylococcus aureus (MRSA) infections. Indeed, multidrug-resistant clones of MRSA for which the only available effective antibacterial agent is vancomycin have recently been identified. Recent reports describing the therapeutic failure of vancomycin for MRSA infections have aroused considerable concern regarding the emergence of MRSA strains for which there will be no effective therapy.1-3 The mechanism of reduced susceptibility in these staphylococcal strains has not been identified, although data indicate that it is not the same as the vancomycin-resistance mechanism in enterococcal strains.4Keywords
This publication has 10 references indexed in Scilit:
- Characterization of Staphylococci with Reduced Susceptibilities to Vancomycin and Other GlycopeptidesJournal of Clinical Microbiology, 1998
- Decreased Susceptibilities to Teicoplanin and Vancomycin among Coagulase-Negative Methicillin-Resistant Clinical Isolates of StaphylococciAntimicrobial Agents and Chemotherapy, 1998
- Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinThe Lancet, 1997
- Suppression of beta-lactam antibiotic resistance in a methicillin- resistant Staphylococcus aureus through synergic action of early cell wall inhibitors and some other antibioticsJournal of Antimicrobial Chemotherapy, 1997
- Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureusJournal of Bacteriology, 1997
- Testing the Efficacy of a Molecular Surveillance Network: Methicillin-ResistantStaphylococcus aureus(MRSA) and Vancomycin-ResistantEnterococcus faecium(VREF) Genotypes in Six Hospitals in the Metropolitan New York City AreaMicrobial Drug Resistance, 1996
- Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1994
- Co-transfer of vancomycin and other resistance genes fromEnterococcus faecalisNCTC 12201 toStaphylococcus aureusFEMS Microbiology Letters, 1992
- THE FINE STRUCTURE OF DIPLOCOCCUS PNEUMONIAE The Journal of cell biology, 1964